ZyVac-TCV Bangladesh Study

计划入组 4,000 人 · 首次发布于 2025 年 1 月 3 日

Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV

计划入组 624 人 · 首次发布于 2025 年 4 月 10 日

Co-administration Study of OCV, TCV and MR

计划入组 2,117 人 · 首次发布于 2023 年 3 月 16 日

TCV-114

TCV-309

TCV-295

PROMOMED TOV

Ukraine

SVETAN TOV

Ukraine

TCI CO., LTD.

Taiwan

BenchSci and argenx Sign Two-Year Enterprise Agreement to Deploy AI-Driven Preclinical Drug Discovery Platform

BenchSci Extends AI Partnership with Merck for Preclinical Disease Biology Research

Trivalent Salmonella Vaccine Shows Strong Immune Response in Phase 1 Trial